5th Edition Excellence in Real World Evidence and Data Utilization

September  20- 21, 2023
Philadelphia, PA

The 5th Edition Excellence in Real World Evidence and Data Utilization Conference will provide insights to improve patient outcomes and treatment efficacy through the utilization of real-world data and evidence throughout the drug lifecycle.  Hear from leading industry experts from pharmaceuticals, biotech, and medical device companies with responsibilities with RWE and HEOR across diverse therapeutic expertise that address the interpretation of regulatory guidance, synthesize and model data and evidence, and determine value from the data.

Key Speakers Include

Charles Makin
Global Head, HEOR, HTA & RWE

Biogen
Amit Kulkarni
Head of Health Economic Modeling and Decision Sciences

Otsuka Pharmaceutical Companies (U.S.)
Weili He, PhD, ASA Fellow
Distinguished Research Fellow, Head of Medical Affairs and Health Technology Assessment Statistics

AbbVie
John Cai
Executive Director RWD Analytics and Innovation

Merck
Boxiong Tang, MD, PhD
Executive Director, Health Economics and Outcomes Research (HEOR) - Global Medical Affairs

BeiGene, Ltd

 Key Topics

  • Rising Above the Noise: Basing Drug Price on Drug Value
  • Analyzing RWE to Best Understand Your Patient Population: Diversity & Inclusion Strategies 
  • Integrating Data Sources for Optimal Success in Randomized Trials and Real World Evidence
  • Navigating the Regulatory Guidelines and Guidance for Optimal Submissions, Approvals, and Outcomes
  • Dissecting Causal Inference Utilized for Real World Evidence Generation
  • Discussing Tokenization of Clinical Trials for (Long Term) Follow Up of Trial Subjects Using RWD
 
Registration

For registration cost and group discount please contact:

Ayis Panayi, Digital Marketing & PR
Email: ayisp@marcusevanscy.com